#United States #New York #Class Action #Shareholder Rights #Monteverde Law

Major Shareholder Alerts: Upcoming Votes on Mergers

As the landscape of corporate mergers and acquisitions continually shifts, shareholders of several prominent companies are urged to stay informed about crucial upcoming votes that could impact their investments. Class Action Attorney Juan Monteverde from Monteverde & Associates PC has been a relentless advocate for shareholder rights, recently announcing significant investigations involving companies such as Cross Country Healthcare, Equitable Holdings, Axalta Coating Systems, and Citizens National Corporation. Here’s what you need to know about these developments.

Cross Country Healthcare, Inc. (NASDAQ: CCRN)

One of the notable happenings is the proposed sale of Cross Country Healthcare to KL Criss Cross Intermediate, LLC. The terms suggest that shareholders are expected to receive $13.25 per share in cash. The urgency of this decision is underscored by the upcoming shareholder vote set for July 16, 2026.

For shareholders of Cross Country, understanding the implications of this sale is vital. The amount on offer may reflect the company's perceived value, but a vote in favor from shareholders can facilitate a smoother transition.

To gather more information, shareholders can visit Monteverde's Cross Country case page. As always, accessing legal support is free and carries no obligations.

Equitable Holdings, Inc. (NYSE: EQH)

In another significant merger, Equitable Holdings is poised to merge with Corebridge Financial, Inc. This merger proposes that shareholders of Equitable will possess approximately 49% of the combined entity upon closing. The shareholder vote for this merger is scheduled for July 30, 2026.

Shareholders must evaluate how the merger aligns with their interests and long-term goals. For more details, shareholders are encouraged to click on the link to Monteverde's Equitable case page.

Axalta Coating Systems Ltd. (NYSE: AXTA)

Axalta Coating Systems will undergo a transformation through its sale to Akzo Nobel N.V., offering shareholders a trade of 0.6539 shares of AkzoNobel stock for each Axalta common stock share. With a vote set for August 5, 2026, shareholders should analyze the potential impact this may have on their current holdings. Companies with a robust history in share performance can assure investors of stability, but every decision should be backed by thorough consideration.

More can be discovered about this merger by viewing the information available on Monteverde's Axalta case page.

Citizens National Corporation (OTCID: CZNL)

Lastly, Citizens National Corporation is expected to send out 2.10 common shares of Peoples Bancorp, Inc. to its shareholders, along with cash of $8.00 per share, in a merger with Peoples Bancorp. The shareholder vote for this deal is scheduled for August 6, 2026.

For more insight, shareholders can visit Monteverde's Citizens National case page to access further information regarding the merger and the advocacy efforts being championed by Monteverde & Associates.

The Role of Monteverde & Associates

Monteverde & Associates PC has established a robust reputation, recovering millions for shareholders in recent years, and has been recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. They emphasize that not all law firms have the same approach and results, making it essential for shareholders to communicate directly with their legal counsel about prior successes and strategies in class action lawsuits.

Their national class action firm operates from the Empire State Building in New York City, providing their services to investors across the United States. The firm stands firmly committed to ensuring accountability, reminding shareholders that no entity is above the law.

For more details or to receive guidance, shareholders can reach out to Juan Monteverde, Esq. directly at (212) 971-1341 or via email at [email protected].

In summary, as the voting dates approach, it is crucial for shareholders to engage with these topics to fully understand the potential implications for their investments. Staying informed is vital in ensuring that they make educated decisions during this pivotal period in corporate governance.